Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2015. Start Trial.
Date Value
October 23, 2026 4.209
October 22, 2026 4.299
October 21, 2026 4.276
October 20, 2026 4.231
October 19, 2026 3.906
October 16, 2026 3.681
October 15, 2026 3.917
October 14, 2026 3.794
October 13, 2026 3.895
October 12, 2026 4.040
October 09, 2026 4.299
October 08, 2026 4.254
October 07, 2026 3.816
October 06, 2026 4.153
October 05, 2026 4.792
October 02, 2026 4.927
October 01, 2026 4.950
September 30, 2026 5.904
September 29, 2026 5.926
September 28, 2026 6.094
September 25, 2026 5.780
September 24, 2026 6.038
September 23, 2026 5.904
September 22, 2026 6.420
September 21, 2026 6.252
Date Value
September 18, 2026 6.173
September 17, 2026 6.061
September 16, 2026 5.971
September 15, 2026 6.201
September 14, 2026 6.330
September 11, 2026 5.971
September 10, 2026 6.179
September 09, 2026 6.240
September 08, 2026 6.802
September 04, 2026 6.925
September 03, 2026 6.678
September 02, 2026 6.936
September 01, 2026 6.757
August 31, 2026 6.790
August 28, 2026 6.745
August 27, 2026 6.914
August 26, 2026 6.947
August 25, 2026 7.335
August 24, 2026 7.082
August 21, 2026 7.194
August 20, 2026 7.104
August 19, 2026 7.228
August 18, 2026 7.076
August 17, 2026 6.644
August 14, 2026 6.487

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Corcept Therapeutics, Inc. 13.13
Alumis, Inc. 1.927
ANI Pharmaceuticals, Inc. 2.793
Veru, Inc. 1.346
Johnson & Johnson 7.789

Price to Book Value Related Metrics

PS Ratio 58.95
Price 3.75
Earnings Yield -15.61%
Market Cap 524.34M